Study #2020-1083
Glutamine PET Imaging of Colorectal Cancer
MD Anderson Study Status
Not Accepting
Treatment Agent
Carbon C 11 Glutamine, Fluorine F 18 L-glutamate Derivative BAY94-9392
Description
The clinical trial studies how well 11C-glutamine and 18F-FSPG positron emission tomography (PET) imaging works in detecting tumors in patients with metastatic colorectal cancer compared to standard imaging methods such as magnetic resonance imaging (MRI) or computed tomography (CT) scanning.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
RAS Wild Type, Stage IV Colorectal Cancer, Stage IVA Colorectal Cancer, Stage IVB Colorectal Cancer
Study phase:
Phase I
Physician name:
Simone Krebs
Department:
Nuclear Medicine
For general questions about clinical trials:
1-833-676-1615
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.